New York · G0328

Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in New York

New York Medicare Avg
$17.53
1% below national avg
National Medicare Avg
$17.63
All states combined
Billed Charge (NY)
$49.80
What providers submit
Est. Commercial (NY)
$43.83
National avg: $39.49
Est. Cash / Self-Pay (NY)
$26.85
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

11.2K
Services in NY
516
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New York

Provider Medicare Services
Weg, Arnold MD $17.69 587
Lempel, Herbert M.D. $17.69 252
Grunseid, Fred M.D. $17.69 196
Berger, Mitchell MD $17.69 182
Allen, Marc DO $17.69 166

New York Pricing in Context

In New York, CPT code G0328 (Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous) carries an average Medicare payment of $17.53 — 1% below the national benchmark of $17.63. 516 providers across the state submitted claims for this procedure in 2023, performing 11.2K total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New York is $49.80, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in New York lands near $43.83, with self-pay cash prices typically around $26.85. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost in New York?

The average Medicare payment for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in New York is $17.53, which is 1% below the national average of $17.63. Providers in NY typically bill $49.80 for this procedure.

What does Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cost with insurance in New York?

With commercial insurance in New York, Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs an estimated $43.83. Without insurance, the estimated cash price is $26.85. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in New York?

516 providers in New York billed Medicare for Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous in 2023, performing 11.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous cheaper in New York than the national average?

Yes — Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 Simultaneous costs 1% below the national average in New York. The state average Medicare payment is $17.53 compared to $17.63 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial